The Right RESI South Registration for You

By Caitlin Dolegowski, Marketing Manager, LSN

Caiti

The RESI South Conference at The Whitley Atlanta Buckhead Hotel on March 25, 2024. The conference, which has served as a catalyst for connecting early-stage life science companies with investors and licensing partners for over a decade will host the event in Atlanta, Georgia for the first time. Life Science Nation anticipates 250+ early-stage investors to register for this event, along with 250+ early-stage startup companies spanning the silos of drugs, devices, diagnostics, and digital health.

Being so early-stage focused, RESI attracts many different types of attendees, and to accommodate that we have a few different registration options. Read through the graph below to figure out what registration option is best for you.

Registration-Type-Chart

Register before Friday, February 23 to save $300 with the Early Bird Rate. Only applicable to some registrations, see prices here.

For additional help in finding your registration type, reach out to the business development team at salescore@lifesciencenation.com to book a meeting so we can assist in figuring out the right registration type for you.

RESI-South-2024_02062024.

Register-now-button-new

RESI-SPAIN-1100

Investors and Licensing Partners, Voting with Their Feet Making the Case for RESI South

By Dennis Ford, Founder and CEO of Life Science Nation, Creator of the RESI Conference Series

The secret is out, and LSN sees firsthand that the Southeastern states have been an under served nascent marketplace for discovering early-stage technology assets. Investors have told me that “it’s booming in the South,” with highly competitive technology assets at more reasonable valuations, making for a dynamic marketplace for identifying and investing in early-stage companies across drugs, devices, diagnostics, and digital health.

Over the last six months, I have become familiar with the seven southeast states (GA, VA, NC, SC, AL, TN, and FL) partnered with LSN as co-developers of the RESI South March 25-27th event in Atlanta. A common theme is running through this multi-state alliance: each state seems to have broken the code that to create a life science innovation economy, you need the buy-in and deep participation from academia, industry, and government. In this cross-sector leadership dynamic, the magic happens with a concentration of industry players, a highly educated workforce, and a supportive environment for startups and established companies where innovation can flourish.

Each state in the southeast alliance checks off all the boxes with a preponderance of diverse clusters throughout their region, a high concentration of BioTech, MedTech, and HealthCare companies, and strong support from hospitals, colleges, and research institutions contribute to its dynamic life sciences landscape.

I have witnessed firsthand how each state has a unique and dynamic ecosystem of government, academic, and industry stakeholders working together. Each state’s life sciences industry is not exclusively based in one metro area. There are multiple clusters around the state. This geographical diversity has contributed to the industry’s dynamism.

The last puzzle piece is investment and incentives, and we are seeing a combination of grants, loans, capital infrastructure investments, tax incentives, and workforce programs. These investments have created thousands of jobs and propelled the development of new therapies, devices, and scientific advancements that improve patient health and well-being in the Southeast region and worldwide.

LSN has an investor and licensing partner network of over four thousand entities that leverage LSN and the RESI conference series to identify and invest in companies for their portfolios and product pipelines. RESI South is currently seeing a brisk signup rate and is expecting 300 investors and licensing partners to participate in the one-day face-to-face meeting in Atlanta and the two-day virtual global meeting on March 25- 27.

RESI-South-2024_02062024.

Register-now-button-new

RESI-SPAIN-1100

The Value of the RESI Innovator’s Pitch Challenge (IPC) 

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

Life Science Nation (LSN) prepares early-stage entrepreneurs for their Global Roadshow Campaign. There are many tools in the LSN toolkit that we provide to make this happen. One of the tools is the Innovator’s Pitch Challenge (IPC). A key component of the Redefining Early Stage Investments (RESI) Conference Series, the Innovator’s Pitch Challenge (IPC), is an opportunity for early-stage life science and healthcare companies to apply to gain additional exposure to conference attendees and pitch directly to a panel of judges, featuring active investors and industry experts. Each finalist company also prepares a posterboard to be showcased in the exhibit hall and competes for “RESI Cash,” which attendees use to “invest” in their favorite presenters for the final prizes. The value of the Innovator’s Pitch Challenge comes from the real-time critique IPC finalists receive from the judging panel and the experience the finalists gain by pitching their technology to relevant industry leaders.

We are accepting applications for the RESI South 2024 Innovator’s Pitch Challenge until Wednesday, February 21. Learn more about the IPC and apply here!

Hear from past IPC finalists and Investor Judge: 

Vanessa WilliamsonVanessa Williamson, CEO, Gliachem:“A 4-minute pitch is not easy. There is an opportunity to add a bunch more content than you would with just a standard elevator pitch, but you can’t overload. Coming up with a succinct message that focused on the problem, solution, differentiation and market opportunity was key. As tempting as it was to get deep into the science, we focused on the business opportunity. The LSN and RESI resources were also invaluable. We attended the prep session you offered and followed the recommendations with respect to focus.”


Alberto Ramos VernieriDr. Alberto Ramos Vernieri, Chief Scientific Officer, Untech:“This prize is exactly that because the judges of the contest are people with a lot of experience and well recognized in the field. Each question from this kind of person is always useful to learn more about those things you can’t learn in other ways.”


Dr. Gennady Bratslavsky, Co-Founder & Partner at Avicella Capital:“An opportunity for us to have a good deep look during the presentations. It also gives an opportunity to provide feedback…It is an opportunity to put their best foot forward and an opportunity to have great exposure.”


David MedinaDavid Medina, PhD, Co-founder at Novaurum Biosciences:“I had the opportunity to pitch for the first time at RESI in Boston.  I was impressed by the quality of the questions I was asked by the investor judges, and it was great to be able to continue the conversation over a drink at the end of the day. We are currently still in conversation with some of them. I also think it helped us get more meetings with investors at RESI. A great experience!” 

To learn more and hear about how to prepare for the IPC, LSN offers free webinars. You can listen here to a previous recording Preparing for the Innovator’s Pitch Challenge.

Applications for the Innovator’s Pitch Challenge are now open for RESI South.

RESI-South-2024_02062024.

Register-now-button-new

Introducing Panelists on the Seed Funds Panel at RESI South 

Joey Wong, Senior Investor Research Analyst, Hong Kong BD, LSN

Life Science Nation (LSN) has curated a program of investor panels for our first RESI South, set to take place in person on March 25th in Atlanta, GA and virtually on March 26-27. We are thrilled to announce a compelling lineup for the Seed Funds panel, featuring 5 dynamic investors who specialize in providing seed-stage financing to startups in the life science and healthcare sectors.

The discussion will center on strategies and approaches on investing in the earliest stage of life science/healthcare assets. The panelists will delve into considerations investors face when dealing with high-risk, high-reward opportunities, what they look for when assessing these prospects, tactical advice for entrepreneurs seeking seed-stage financing, and much more. Our panelists represent a diverse range of backgrounds, expertise and geographic focuses, each bringing a unique perspective and wealth of experience to the table, making this discussion invaluable for fundraising entrepreneurs or investors looking to expand their portfolio. Please see below for the panelist lineup:


Peter Alff
Senior Venture Partner
Orange Grove Bio

Sinclair Dunlop
Managing Partner
Epidarex Capital

Deborah Hemingway
Managing Partner
Ecphora Capital

Michelle (Waye) Leeuwon
Program Manager for Product Development
Cancer Prevention and Research Institute of Texas (CPRIT)

Ron Levin
Managing Partner
Alumni Ventures

At LSN, we recognize the pivotal role that early-stage investments play in driving innovation and shaping the future of healthcare, and through our RESI panels, we aim to cultivate dialogue between investors and entrepreneurs, offering actionable insights and unparalleled networking opportunities.

We look forward to fostering connections and communications between the local ecosystem and the broader life science and healthcare innovation community through our inaugural RESI South. Join us in-person on March 25th or virtually on March 26-27, and we can’t wait to see you there!

RESI-South-2024_02062024.

Register-now-button-new

RESI-SPAIN-1100

LSN: Navigating the Path to Commercialization

By Dennis Ford, Founder and CEO of Life Science Nation, Creator of the RESI Conference Series

By helping startups develop compelling narratives for their fundraising campaigns and facilitating strategic partnerships through its extensive network, LSN plays a pivotal role in bridging the gap between academia and industry. Life Science Nation has developed a set of products and services that help startups navigate the fundraising chasm and find the right partners to aid them in their journey to commercialization. These challenges include:

  1. Navigating a New Field: Moving from academia to industry requires adapting to a new environment, understanding the rules, and building a professional network within the life science industry.
  2. Acquiring New Skillsets: Scientists-Entrepreneurs need to be open to learning or having staff that understand Sales, Marketing, and Business Development.
  3. Fundraising, Licensing, and Collaboration Trends: Early-stage life science companies face the challenge of staying informed about investment trends and securing funding, especially in the face of broader market challenges and uncertainties.
  4. Competition and Innovation: Rapid innovation and competition characterize the life science industry. To remain competitive, startups must stay abreast of the latest scientific advancements and disruptive technologies.
  5. Networking and Collaboration: Building a strong network of collaborators, investors, and partners is essential for early-stage life science companies. This includes understanding the dynamics of potential partnerships and effectively engaging with investors and partners.
  6. Market Dynamics and Global Expansion: Understanding market dynamics, both locally and globally, is crucial for startups. They must also develop a strategic plan for global expansion and navigate the complexities of launching and executing a global campaign and roadshow.
  7. Fostering Ongoing Partnerships: Successful partnerships require ongoing effort and a dedicated plan to maintain a consistent pipeline of partner meetings, even as these meetings ebb and flow over time.

Contrary to the popular assumption that science is enough, and focusing on that will lead to successful fundraising, making the transition from a scientist to an entrepreneur requires flexibility, passion, and a lot of drive and determination. A scientist has to transform and adapt, learning new skill sets and entering a new world, but those that want it can be extremely successful. Let us help you on that journey.

RESI-South-2024_02062024.

Register-now-button-new

RESI-SPAIN-1100

Confirmed Early-Stage Investors at RESI South in March 

By Faith Patenaude, Investor Research Analyst, LSN

Faith

Life Science Nation brings RESI to the south! The next RESI event is approaching on Monday, March 25th at The Whitley Atlanta Buckhead in Atlanta, Georgia. This event will be followed by two days of virtual partnering on March 26th and 27th. Monday will showcase our Investor Panels, esteemed Innovator’s Pitch Challenge, and Entrepreneur Workshops led by industry experts. Additionally, one-on-one partnering meetings will be available throughout all three days.

RESI South will feature over 250 investors within big pharma, venture capital funds, angel groups, family offices, and more. Investors invited and registered have been vetted by LSN’s investor research team to ensure those attending have active interest in early-stage life science investment opportunities. The team works to welcome relevant investors who share focus and interests aligned with those of the participating startups. Our Partnering Platform allows attendees to easily match with those of best fit. RESI presents an exceptional opportunity for early-stage startups, service providers, and investors to forge meaningful connections and expand their network within the life science sector.

Save up to $500 with our super early bird rate – ending tomorrow, Friday February 9th. Register to join us in Atlanta. 

Register-now-button-new

Below are a selected number of investors attending RESI South and more on the way:

CI-02082024

RESI-South-2024_02062024.

RESI-SPAIN-1100

RESI South Calling for Global Tech Hubs (Incubators, Accelerators, Universities, and More)

By Erika Wu, Business Development Manager, Global Tech Hubs, LSN

Early-stage life science startups that are affiliated with a tech hub (incubator, accelerator, university, non-profit, or regional/government agency) are eligible for up to $500 off to Life Science Nation’s RESI South, March 25 – 27th, in Atlanta, Georgia. To redeem a unique discount code, please reach out to Erika Wu at e.wu@lifesciencenation.com

Tech hubs are also eligible to save 50% off all sponsorship levels at RESI. This is a great opportunity to:

  1. Showcase startups’ technologies from your tech hub with the Innovator’s Pitch Challenge (IPC). Get a group rate for your startups!
  2. Host a workshop
  3. Get featured in LSN’s Next Phase and Tech Hub newsletters
  4. Showcase your tech hub’s services and value proposition at an exhibition booth

If your startups are not in fundraising mode, they can attend RESI South with an “Audience Access Pass” for $595, which gets access to view all in-person sessions (March 25th) including IPC pitch sessions, investor-led panels, workshops, exhibition, and a post-RESI networking reception.

Tech hubs currently registered for RESI South 2024 – Sign Up Here:

CTH-02082024

For any questions, please reach out to Erika Wu at e.wu@lifesciencenation.com

RESI-South-2024_02062024.

Register-now-button-new

RESI-SPAIN-1100